{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T10:57:30Z","timestamp":1773658650369,"version":"3.50.1"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2007,3,2]],"date-time":"2007-03-02T00:00:00Z","timestamp":1172793600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"published-print":{"date-parts":[[2007,11,23]]},"DOI":"10.1007\/s11255-006-9157-7","type":"journal-article","created":{"date-parts":[[2007,3,1]],"date-time":"2007-03-01T17:33:25Z","timestamp":1172770405000},"page":"1069-1077","source":"Crossref","is-referenced-by-count":14,"title":["Safety and tolerability of extended-release oxybutynin once daily in urinary incontinence: combined results from two phase 4 controlled clinical trials"],"prefix":"10.1007","volume":"39","author":[{"given":"Robert B.","family":"Armstrong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roger R.","family":"Dmochowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter K.","family":"Sand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott","family":"MacDiarmid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2007,3,2]]},"reference":[{"key":"9157_CR1","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/s00345-002-0301-4","volume":"20","author":"W Stewart","year":"2003","unstructured":"Stewart W, Van Rooyen JB, Cundiff GW et al (2003) Prevalence and burden of overactive bladder in the United States. World J Urol 20:627\u2013636","journal-title":"World J Urol"},{"key":"9157_CR2","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1046\/j.1464-410x.1998.00717.x","volume":"81","author":"P Abrams","year":"1998","unstructured":"Abrams P, Freeman R, Anderstrom C et al (1998) Tolterodine, a new antimuscarinic agent: as effective but better tolerated than oxybutynin in patients with an overactive bladder. Br J Urol 81:801\u2013810","journal-title":"Br J Urol"},{"key":"9157_CR3","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s001929970003","volume":"10","author":"HP Drutz","year":"1999","unstructured":"Drutz HP, Appell RA, Gleason D et al (1999) Clinical efficacy and safety of tolterodine compared to oxybutynin and placebo in patients with overactive bladder. Int Urogynecol J 10:283\u2013289","journal-title":"Int Urogynecol J"},{"key":"9157_CR4","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1016\/S0022-5347(05)68810-6","volume":"161","author":"RU Anderson","year":"1999","unstructured":"Anderson RU, Mobley D, Blank B et al (1999) Once daily controlled versus immediate release oxybutynin chloride for urge urinary incontinence. J Urol 161:1809\u20131812","journal-title":"J Urol"},{"key":"9157_CR5","doi-asserted-by":"crossref","unstructured":"Gleason DM, Susset J, White C et al, for the Ditropan XL Study Group (1999) Evaluation of a new once-daily formulation of oxybutynin for the treatment of urinary urge incontinence. Urology 54:420\u2013423","DOI":"10.1016\/S0090-4295(99)00259-9"},{"key":"9157_CR6","unstructured":"Versi E, Appell R, Mobley D, et al, for the Ditropan XL Study Group (2000) Dry mouth with conventional and controlled-release oxybutynin in urinary incontinence. Obstet Gynecol 95:718\u2013721"},{"issue":"Suppl 6A","key":"9157_CR7","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/S0090-4295(97)00599-2","volume":"50","author":"RA Appell","year":"1997","unstructured":"Appell RA (1997) Clinical efficacy and safety of tolterodine in the treatment of overactive bladder: a pooled analysis. Urology 50(Suppl 6A):90\u201396","journal-title":"Urology"},{"key":"9157_CR8","doi-asserted-by":"crossref","unstructured":"Van Kerrebroeck P, Kreder K, Jonas U, et al, for the Tolterodine Study Group (2001) Tolterodine once-daily: superior efficacy and tolerability in the treatment of overactive bladder. Urology 57:414\u2013421","DOI":"10.1016\/S0090-4295(00)01113-4"},{"key":"9157_CR9","doi-asserted-by":"crossref","unstructured":"Appell RA, Sand P, Dmochowski R, et al, for the OBJECT Study Group (2001) Prospective randomized controlled trial of extended-release oxybutynin chloride and tolterodine tartrate in the treatment of overactive bladder: results of the OBJECT study. Mayo Clin Proc 76:358\u2013363","DOI":"10.1016\/S0025-6196(11)62382-3"},{"key":"9157_CR10","doi-asserted-by":"crossref","unstructured":"Diokno AC, Appell RA, Sand PK, et al, for the OPERA Study Group (2003) Prospective, randomized, double-blind, study of the efficacy and tolerability of the extended-release formulations of oxybutynin and tolterodine for overactive bladder: results of the OPERA trial. Mayo Clin Proc 78:687\u2013695","DOI":"10.4065\/78.6.687"},{"key":"9157_CR11","unstructured":"Detrol\u00ae LA tolterodine tartrate extended release capsules [prescribing information] (2004) Kalamazoo, MI: Pharmacia & Upjohn Company; April 2004. Available at: http:\/\/pfizer.com\/pfizer\/download\/uspi_detrol_la.pdf. Accessed September 27, 2005"},{"key":"9157_CR12","unstructured":"Ditropan XL\u00ae (oxybutynin chloride) Extended Release Tablets [prescribing information] (2004) Raritan, NJ: Ortho-McNeil Pharmaceutical, Inc.; June 2004. Available at: http:\/\/www.orthomcneil.com\/products\/pi\/pdfs\/ditropanxl.pdf#zoom\u00a0=\u00a0100 . Accessed September 27, 2005"},{"key":"9157_CR13","unstructured":"Schmidt RA for the Oxybutynin XL Study Group (1998) Efficacy of controlled-release, once-a-day, oxybutynin chloride for urge urinary incontinence [abstract]. Presented at: 28th Annual Meeting of the International Continence Society; September 14\u201317, 1998; Jerusalem, Israel. Abstract 188"},{"key":"9157_CR14","first-page":"329","volume":"37","author":"JG Malone-Lee","year":"2000","unstructured":"Malone-Lee JG, O Connell M (2000) Pooled analysis of efficacy and safety of Ditropan XL in patients with overactive bladder [abstract]. Eur Urol 37:329","journal-title":"Eur Urol"},{"key":"9157_CR15","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1023\/A:1021372426421","volume":"34","author":"A Diokno","year":"2002","unstructured":"Diokno A, Sand P, Labasky R et al (2002). Long-term safety of extended-release oxybutynin chloride in a community-dwelling population of participants with overactive bladder: a one-year study. Int Urol Nephrol 34:43\u201349","journal-title":"Int Urol Nephrol"},{"key":"9157_CR16","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1097\/01.ju.0000173076.93737.d5","volume":"174","author":"SA MacDiarmid","year":"2005","unstructured":"MacDiarmid SA, Anderson RU, Armstrong RB, Dmochowski RR (2005) Efficacy and safety of extended release oxybutynin for the treatment of urge incontinence: an analysis of data from 3 flexible dosing studies. J Urol 174:1301\u20131305","journal-title":"J Urol"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-006-9157-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11255-006-9157-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-006-9157-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,20]],"date-time":"2020-04-20T08:29:25Z","timestamp":1587371365000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11255-006-9157-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,3,2]]},"references-count":16,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2007,11,23]]}},"alternative-id":["9157"],"URL":"https:\/\/doi.org\/10.1007\/s11255-006-9157-7","relation":{},"ISSN":["0301-1623","1573-2584"],"issn-type":[{"value":"0301-1623","type":"print"},{"value":"1573-2584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,3,2]]}}}